I want all to know that Sean called me directly yesterday and we had a very good conversation about the pros and cons of using the InPen. I am glad that Dexcom is pairing with the InPen and hope that it can be useful to me in the future. There are certainly FDA hoops that the company must comply with and cautions of not overdosing on insulin that focus the testing of the pen and the necessary dosing calculations. A new generation of the InPen is coming out and I would be open to trying it.
Sean suggested that the Novolog cartridges may have expired or been submitted to too much heat or cold this summer. So I contacted Novo Nordisk and they are replacing my 5 cartridge package. The possibility of the Novolog having lost potency was increased by the fact that the pharmacist had told me it was the last carton she had. So it may have been sitting for quite some time, but not yet officially expired. So I will use the InPen with the replaced cartridges (and mail back the old cartridges) to see if that makes a difference in keeping my BG in the normal range while using the InPen.
Thanks to Sean for giving attention to this and taking my peer review comments!